Metabolic & Cardiometabolic
oxidized LDL (not native LDL) initiates atherogenesis
In plain terms: Does LDL only cause heart disease after it gets oxidized?
Part of: 🔍 seed oils
Oxidized LDL is real and drives many steps of plaque biology, but antioxidant trials failed to cut heart attacks and LDL/ApoB particle number is the proven causal driver, so "native LDL is harmless until oxidized" is overstated.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Schiopu 2023 · Ann Med | observational | supports | moderate | Elevated circulating soluble LOX-1 (the oxLDL receptor) prospectively predicted first myocardial infarction, supporting a real contributory role for oxLDL biology. |
| Williams 1998 · Arterioscler Thromb Vasc Biol | mechanism | mixed | moderate | Subendothelial retention of native atherogenic lipoproteins is the pivotal initiating event, with modification a downstream consequence rather than an obligatory precondition. |
| Violi 2022 · Free Radic Biol Med | meta-analysis | contradicts | moderate | Despite strong oxLDL mechanism, interventional vitamin E antioxidant trials failed to reduce cardiovascular events, arguing against oxidation being the necessary causal gate. |
| Ference 2017 · European Heart Journal | observational | contradicts | high | EAS consensus from Mendelian-randomization + RCTs: LDL/ApoB particle number causes ASCVD log-linearly — native LDL is NOT benign, undercutting \"must oxidize first\". |
| Meisinger 2005 · Circulation | observational | supports | high | In healthy middle-aged men, plasma oxLDL was a strong independent predictor of future coronary events — human prospective support. |
| Steinberg 1989 · N Engl J Med | mechanism | supports | moderate | Landmark \"beyond cholesterol\" hypothesis: oxidative modification makes LDL atherogenic via scavenger-receptor foam-cell uptake — foundational mechanism. |
| An 2022 · J Am Coll Cardiol | meta-analysis | tested-null | high | Broad micronutrient meta-analysis: vitamin E and most antioxidants showed no CVD benefit, reinforcing that lowering oxidation is not the lever LDL-lowering is. |
| Alkhenizan 2004 · Saudi Med J | meta-analysis | tested-null | moderate | Nine vitamin-E RCTs (n=80,645): no reduction in total or CVD mortality — antioxidant strategy fails to confirm oxidation-as-initiator. |
| Zhao 2024 · Curr Med Chem | mechanism | contradicts | moderate | Reviews multiple non-oxidative LDL modifications (carbamylation, glycation, enzymatic) as underappreciated atherogenic drivers, arguing oxidation is not the sole modification that renders LDL atherogenic. |
| Chisolm 2000 · Free Radic Biol Med | mechanism | mixed | moderate | Steinberg-group overview: oxLDL present in lesions and active in vitro, but authors concede where/how LDL oxidizes in vivo and its in-vivo relevance remain unproven. |
| Torzewski 2021 · Int J Mol Sci | observational | contradicts | low | Argues early lesion initiation proceeds via enzymatically (non-oxidatively) modified LDL and can begin without inflammation, contradicting the claim that oxidation is the required trigger. |
| Ye 2013 · PLoS One | meta-analysis | tested-null | high | Pooled antioxidant-vitamin RCTs (vit E, C, beta-carotene) showed no reduction in cardiovascular events — predicted benefit of blocking LDL oxidation did not materialize. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.